Taztia Xt

   
Google
 
Web NewDrugInformation.com

Taztia Xt


Drug - Taztia Xt
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Diltiazem Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 120MG
The potency of the active ingredient(s), Diltiazem Hydrochloride. May repeat for multiple part products.

Applicant - ANDRX PHARMS
The firm name holding legal responsibility for Taztia Xt. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075401
The FDA assigned number to Taztia Xt. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Taztia Xt. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB4
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 10, 2003
The date Taztia Xt was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Taztia Xt. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Taztia Xt is in. Format is RX, OTC, DISCN.

Applicant Full Name - Andrx Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Taztia Xt.

Taztia Xt